ArticleInternational journal of nanomedicine2026

Inhalable Albumin Nanoparticles Co-Delivering Dihydroartemisinin and Nintedanib Attenuate Pulmonary Fibrosis by Suppressing TGF-β1/Smad2/3 Signaling.

Caopei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.